Hikal Limited (BOM:524735)

Market Cap	33.07B
Revenue (ttm)	18.33B
Net Income (ttm)	633.00M
Shares Out	123.30M
EPS (ttm)	5.14
PE Ratio	52.13
Forward PE	31.28
Dividend	1.60 (0.59%)
Ex-Dividend Date	Sep 2, 2025

Volume	44,550
Average Volume	25,780
Open	305.80
Previous Close	307.35
Day's Range	281.55 - 307.50
52-Week Range	281.55 - 464.50
Beta	0.47
RSI	14.54
Earnings Date	Aug 5, 2025

About Hikal

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal health, biotech, crop protection, and specialty chemicals companies in India, the United States, Canada, Europe, South East Asia, and internationally. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredients (APIs). Its Crop Protection segment manufactures pesticides and herbicides, wh...

• Industry: Pharmaceutical Preparations
• Founded: 1988
• Employees: 2,061
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524735

Financial Performance

In 2024, Hikal's revenue was 18.60 billion, an increase of 4.21% compared to the previous year's 17.85 billion. Earnings were 908.00 million, an increase of 30.46%.